Skip to ContentSkip to Navigation
About us Latest news News News articles

Erythropoietin in heart failure. Effects beyond erythropoiesis

12 January 2011

PhD ceremony: Mr. W.T. Ruifrok, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Erythropoietin in heart failure. Effects beyond erythropoiesis

Promotor(s): prof. W.H. van Gilst, prof. D.J. van Veldhuisen

Faculty: Medical Sciences

 

Heart failure is a serious disease with a poor prognosis, often occurring with co-morbidity including anemia. The focus of this study was to unravel the mechanisms of erythropoietin (EPO) in heart failure. The general outcome of the study is that the positive effects of EPO in heart failure are related to other mechanisms than its role in the formation of red blood cells.

 

Last modified:13 March 2020 01.12 a.m.
View this page in: Nederlands

More news